Study of avastin and tofacitinib for skin amyloidosis
Part of Skin clinical trials.
This trial looks at people with primary cutaneous amyloidosis who have been treated with Avastin Capsules or Tofacitinib Citrate. It aims to track how well these medications work and if they are safe over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and do not have hepatitis B, tuberculosis, or other major health conditions.
- You have been diagnosed with primary cutaneous amyloidosis, macular amyloidosis, or lichen amyloidosis.
- You have visited the clinic for this condition at least 4 times.
- Your medical records show you have taken Avastin Capsules and/or Tofacitinib Citrate.
- You are not currently using other immune-suppressing drugs or biologics (like steroids or methotrexate).
- You do not have nodular or systemic amyloidosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injection (Stapokibart) for people with moderate to severe primary cutaneous amyloidosis, a condition that causes itchy, thickened skin. It aims to see if the drug can safely reduce symptoms in people who haven't gotten enough relief from standard treatments.
This trial is testing a cream called tofacitinib (a type of medicine that helps calm the immune system) for people with early-stage cutaneous T-cell lymphoma (CTCL). The goal is to see if it helps shrink or control the skin lesions safely.
This study tests a drug called tofacitinib, which calms the immune system, in people with ALS. It aims to see if it can slow the disease by blocking an overactive immune response linked to certain genetic patterns.
This trial tests if the drug tofacitinib can help people whose heart inflammation from cancer immunotherapy (called ICI-related myocarditis) does not improve with steroids. If you have this condition, this study may offer a new treatment option.
This trial uses a special PET/CT scan to see if a radioactive tracer can measure changes in amyloid buildup in people with CAPS who have developed a skin reaction to anakinra. It may help doctors understand how the disease is affecting your organs.
This study tests whether taking tofacitinib alone works as well as taking tofacitinib with mesalamine for people with ulcerative colitis who are already in remission. It aims to see if one medication can be stopped without causing a flare-up.
Hear when a new Primary Cutaneous Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.